Press Releases

NORTHAMPTON, MA / ACCESSWIRE / May 13, 2024 / Northern Trust

Last month on Earth Day, Pete Bowker and Daniel Usher trialed brand new e-bikes that the Northern Trust Guernsey team now have readily available for all their team.

The e-bikes are a sustainable and alternative solution for staff intraday local commutes, these e-bikes allow traffic-beating routes to meetings and can avail of the abundant parking solutions across the island.

"So pleased to have secured the two... (continue reading...)

LONDON, UK / ACCESSWIRE / May 13, 2024 / Ecora Resources PLC (LSE:ECOR)(TSX:ECOR) announces that on 13 May 2024, it purchased 50,000 ordinary shares of 2p each in the Company (the "Shares") on the London Stock Exchange through Peel Hunt LLP, in accordance with the terms of its share buyback programme announced on 27 March 2024 (the "Programme"). The shares acquired will be held in treasury.

Date of purchase:

13 May 2024

Aggregate number of ordinary shares purchased:

50,000

... (continue reading...)

Vancouver, British Columbia--(Newsfile Corp. - May 13, 2024) - Silver Elephant Mining Corp.(TSX: ELEF) (OTC: SILEF) (FSE: 1P2)("Silver Elephant" or the "Company")is pleased to announce that its common shares have resumed broker-dealer quotation on the OTC Pink market under the symbol "SILEF" following acceptance by the Financial Industry Regulatory Authority (FINRA) of a Form 211. This follows the Company's completion of voluntary deregistration of its common shares... (continue reading...)

SAN FRANCISCO--(BUSINESS WIRE)-- Balfour Beatty has achieved substantial completion on the Caltrain Electrification project, the first undertaking in North America in which diesel trains and their infrastructure components are transitioned to an electrified system. The milestone signifies the successful turnover of the electrified, 51-mile corridor between San Francisco and San Jose, as Caltrain prepares to transform the system into a faster, more efficient and... (continue reading...)

The heparin market is driven by the increasing prevalence of chronic diseases such as cardiovascular diseases, cancer, and others. This growing demand for anticoagulant therapies is expected to propel the market forward.

The Heparin Market, valued at USD 7.71 billion in 2023, is anticipated to achieve a valuation of USD 9.61 billion by 2031, experiencing a compound annual growth rate (CAGR) of 2.8% throughout the forecast period from 2024 to 2031.